Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults
Clinical trial NCT04785144 · COMPLETED
Trial details
- NCT number
- NCT04785144
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2022-07-05
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.